Clinical Trials on Unresectable Pancreatic Carcinoma in Finland

Total 794 results

National Cancer Institute (NCI)

Recruiting

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Pancreatic Acinar Cell Carcinoma | Pancreatic Adenosquamous Carcinoma | Pancreatic Squamous Cell Carcinoma | Resectable Pancreatic Acinar Cell Carcinoma | Resectable Pancreatic Adenocarcinoma | Resectable Pancreatic Adenosquamous Carcinoma | Resectable Pancreatic Carcinoma

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Recruiting

Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors

Metastatic Pancreatic Neuroendocrine Tumor | Unresectable Pancreatic Neuroendocrine Carcinoma

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Pancreatic Adenocarcinoma | Resectable Pancreatic Carcinoma

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Recruiting

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

Pancreatic Cancer | Pancreatic Adenosquamous Carcinoma | Resectable Pancreatic Adenocarcinoma

United States, Canada
National Cancer Institute (NCI)

Active, not recruiting

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

Carcinoid Tumor | Functioning Pancreatic Neuroendocrine Tumor | Intermediate Grade Lung Neuroendocrine Neoplasm | Locally Advanced Pancreatic Neuroendocrine Tumor | Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm | Low Grade Lung Neuroendocrine Neoplasm | Metastatic Digestive... and other conditions

United States
Sorrento Therapeutics, Inc.

Terminated

Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver Metastases (AntiCEA_CART)

Metastatic Pancreatic Carcinoma

United States
Roger Williams Medical Center
TriSalus Life Sciences

Withdrawn

Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma (PANC-001)

Pancreatic Adenocarcinoma

United States
Tampere University Hospital

Terminated

Pancreatic Stump Closure After Distal Pancreatic Resection

Distal Pancreatic Resections

Finland
Helsinki University Central Hospital

Completed

Pancreatic Exocrine Insufficiency in Acute Pancreatitis (APPEI)

Acute Pancreatitis | Exocrine Pancreatic Insufficiency

Finland
Tampere University

Unknown

New Type of a Pancreaticojejunostomy

Pancreaticojejunostomy After Pancreatic Head Resection

Finland
Incyte Corporation

Terminated

Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205)

Metastatic Urothelial Carcinoma | Unresectable Urothelial Carcinoma

Spain, France, United States, Italy, Japan, Ireland, Slovakia, Austria, Belgium, Canada, Finland, Germany, Poland, Portugal, Romania, United Kingdom
Tampere University Hospital

Terminated

ERAS Protocol in Pancreaticoduodenectomy and Total Pancreatectomy

Pancreatic Cancer | Surgery--Complications | Pancreatic Fistula | Delayed Gastric Emptying | Pancreatic Hemorrhage

Finland
Helsinki University Central Hospital

Withdrawn

Biliary Drainage Preceding Possible Pancreaticoduodenectomy. Are Self-expandable Metallic Stents (SEMS) Superior to Plastic Stents?

Pancreatic Cancer

Finland
Helsinki University Central Hospital

Active, not recruiting

HYPAR Trial - Hydrocortisone vs. Pasireotide in Reducing Pancreatic Surgery Complications (HYPAR)

Pancreatic Neoplasms | Pancreatic Fistula

Finland
Helsinki University Central Hospital

Recruiting

Palliative Pancreatic Duct Stenting in Patients With Inoperable Pancreatic Cancer

Pancreatic Cancer | Pancreatic Duct Stricture

Finland
Helsinki University Central Hospital

Recruiting

Does Pancreatic Stent Decrease the Risk of Pancreatitis After Pancreatic Sphincterotomy for Difficult Cannulation?

Endoscopic Retrograde Cholangiopancreatography

Finland
Helsinki University Central Hospital

Completed

Activated Protein C in Severe Acute Pancreatitis

Acute Pancreatitis

Finland
Helsinki University Central Hospital

Completed

Alfentanil Versus Remifentanil in Patient-controlled Sedation During Endoscopic Retrograde Cholangiopancreatography (ERCP)

Biliary Tract Diseases | Pancreatic Diseases

Finland
National Cancer Institute (NCI)

Completed

Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy (S1115)

Pancreatic Ductal Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage IV Pancreatic Cancer | Pancreatic Acinar Cell Carcinoma

United States
Kuopio University Hospital

Unknown

Laparoscopic Cholecystectomy in Idiopathic Pancreatitis

Idiopathic Pancreatitis

Finland
Turku University Hospital

Completed

PET-CT in Diagnosis of Pancreatic Cystic Neoplasms

Neoplasms | Pancreatic Cancer

Finland
Helsinki University Central Hospital
University of Helsinki

Recruiting

Improvement of Care of Patients Undergoing Pancreaticoduodenectomy

Pancreatic Diseases | Pancreas Cancer

Finland
University of Oulu
Copenhagen University Hospital, Hvidovre

Unknown

Prophylactic Pancreatic Duct Stenting in Acute Necrotizing Pancreatitis (ERPNEC)

Acute Necrotizing Pancreatitis

Finland
Helsinki University Central Hospital

Completed

Dexmedetomidine Versus Placebo in Endoscopic Retrograde Cholangiopancreatography (ERCP) Sedation

Pancreatitis

Finland
Sirtex Medical
Bright Research Partners

Recruiting

Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma Patients (DOORwaY90)

Unresectable Hepatocellular Carcinoma | BCLC Stage B Hepatocellular Carcinoma | BCLC Stage C Hepatocellular Carcinoma | BCLC Stage A Hepatocellular Carcinoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver

Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 | Unresectable Hepatocellular Carcinoma | Metastatic Cholangiocarcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular... and other conditions

United States
National Cancer Institute (NCI)

Completed

Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery

Refractory Pancreatic Neuroendocrine Carcinoma | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2

United States
National Cancer Institute (NCI)

Completed

Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Hepatocellular Carcinoma | Unresectable Hepatocellular Carcinoma

United States
Turku University Hospital

Unknown

Liquid Biopsy in Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma

Finland
Turku University Hospital

Unknown

The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer

Mammary Ductal Carcinoma

Finland
Tampere University Hospital

Completed

Cortisone Treatment for the Prevention of Postoperative Pancreatitis and Pancreatitis-induced Complications After Pancreaticoduodenectomy and Distal Pancreatic Resection

Postoperative Complications | Postoperative Pancreatitis

Finland
Hoffmann-La Roche

Recruiting

A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab (IMbrave251)

Unresectable Hepatocellular Carcinoma

Canada, France, Korea, Republic of, China, Japan, Spain, Belgium, Croatia, Brazil, Austria, Italy, Costa Rica, Germany, Israel, Thailand, Turkey, Russian Federation, United Kingdom, Taiwan, Philippines, India, Chile, Finland, Greece, Sl... and more
Helsinki University Central Hospital

Recruiting

Pre- vs. Postoperative Thromboprophylaxis in Pancreatic Surgery (PREPOSTEROUS2)

Thrombosis | Bleeding | Surgery | Pancreas Cancer | Pancreas Neoplasm

Finland
Tampere University

Suspended

Albumindialysis in Acute Pancreatitis (pancreatitis)

Pancreatitis | Multiple Organ Failure

Finland
Tampere University Hospital
Olfactomics Oy

Recruiting

Differential Mobility Spectrometry (DMS) Based Skin Tumor Analysis

Basal Cell Carcinoma

Finland
Tampere University

Completed

Decrease of Recurrent Pancreatitis

Pancreatitis

Finland
Turku University Hospital

Recruiting

18F-FDG PET/CT Versus 18F-FDG PET/MRI in Detecting Locoregional Recurrence 3 Months After CRT in Head and Neck SCC (HENEPET)

Head and Neck Squamous Cell Carcinoma

Finland
Tampere University Hospital
Orion Corporation, Orion Pharma

Active, not recruiting

The Effect of Vitamin D Substitution on the Development of Chronic Pancreatitis

Chronic Pancreatitis

Finland
Turku University Hospital

Completed

Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer

Squamous Cell Carcinoma of the Head and Neck

Finland
Tampere University Hospital
Olfactomics Oy

Recruiting

Differential Mobility Spectrometry (DMS) Based Oral Tumor Analysis

Oral Squamous Cell Carcinoma

Finland
Helsinki University Central Hospital

Recruiting

Prevention of Chyle-leak After Major Pancreatic Surgery

Pancreatic Cancer | Complication of Surgical Procedure | Lymph Leakage | Chyle Into Mesentery; Extravasation

Finland
Incyte Corporation

Recruiting

A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma (FIGHT-302)

Metastatic Cholangiocarcinoma | Unresectable Cholangiocarcinoma

United States, Canada, Belgium, France, Germany, Italy, China, Spain, Japan, United Kingdom, Netherlands, Switzerland, Austria, Denmark, Finland, Ireland, Israel, Norway, Sweden
Brown University
The Miriam Hospital; Rhode Island Hospital; Memorial Hospital of Rhode Island

Terminated

BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer

Metastatic Pancreatic Cancer

United States
Brown University
GlaxoSmithKline

Completed

A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema (BrUOG-PA205)

Metastatic Pancreatic Cancer

United States
Société des Produits Nestlé (SPN)

Completed

Oral CDX-7108 in Healthy Adults and EPI Subjects

Exocrine Pancreatic Insufficiency

Australia, New Zealand
Faron Pharmaceuticals Ltd

Withdrawn

A Phase I/II Open Label Single Centre Trial to Assess the Safety, Tolerability and Efficacy of Single Dose Neoadjuvant Anti-CLEVER-1 Antibody Bexmarilimab in Localised Renal Cell and Colon Carcinoma (RENACOL)

Carcinoma, Renal Cell | Carcinoma Colon

Finland
Helsinki University Central Hospital

Recruiting

Quick Large Balloon Dilatation for Removal of Large Bile Duct Stones (SHODBADI) (SHODBADI)

Bleeding | Cholangitis | Pancreatitis, Acute

Finland
Brown University
Rhode Island Hospital

Completed

FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

Pancreatic Cancer | Locally Advanced Pancreatic Cancer

United States
Gulam Manji
Regeneron Pharmaceuticals; BioLine Rx

Recruiting

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

Adenocarcinoma | Pancreatic Cancer | Adenocarcinoma of the Pancreas

United States
Brown University
Rhode Island Hospital; Memorial Hospital of Rhode Island; Lifespan

Completed

BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study (278)

Metastatic Pancreatic Cancer

United States

Clinical Trials on Unresectable Pancreatic Carcinoma in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations